These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33806077)
1. Kang YH; Lee JS; Lee NH; Kim SH; Seo CS; Son CG Molecules; 2021 Mar; 26(7):. PubMed ID: 33806077 [TBL] [Abstract][Full Text] [Related]
2. Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells. Yang C; Song J; Hwang S; Choi J; Song G; Lim W Redox Biol; 2021 Nov; 47():102144. PubMed ID: 34562873 [TBL] [Abstract][Full Text] [Related]
3. The Impact of Thymidylate Synthase and Methylenetetrahydrofolate Reductase Genotypes on Sensitivity to 5-Fluorouracil Treatment in Colorectal Cancer Cells. Naghibalhossaini F; Shefaghat M; Mansouri A; Jaberi H; Tatar M; Eftekhar E Acta Med Iran; 2017 Dec; 55(12):751-758. PubMed ID: 29373881 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells. Kurasaka C; Ogino Y; Sato A Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805673 [TBL] [Abstract][Full Text] [Related]
5. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells. Sakatani A; Sonohara F; Goel A Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435 [TBL] [Abstract][Full Text] [Related]
6. Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer. Kumar A; Singh AK; Singh H; Thareja S; Kumar P Med Oncol; 2022 Oct; 40(1):3. PubMed ID: 36308643 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706 [TBL] [Abstract][Full Text] [Related]
8. Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway. Liu H; Liu H; Zhou Z; Parise RA; Chu E; Schmitz JC Cell Commun Signal; 2018 Feb; 16(1):7. PubMed ID: 29458395 [TBL] [Abstract][Full Text] [Related]
9. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Li T; Gao F; Zhang XP Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885 [TBL] [Abstract][Full Text] [Related]
10. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase. Milczarek M; Rossowska J; Klopotowska D; Stachowicz M; Kutner A; Wietrzyk J J Steroid Biochem Mol Biol; 2019 Jun; 190():139-151. PubMed ID: 30923017 [TBL] [Abstract][Full Text] [Related]
11. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of the MEK Inhibitor Cobimetinib and its Potential Application to Colorectal Cancer Cells. Gong S; Xu D; Zhu J; Zou F; Peng R Cell Physiol Biochem; 2018; 47(2):680-693. PubMed ID: 29794421 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines. McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143 [TBL] [Abstract][Full Text] [Related]
14. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance. Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421 [TBL] [Abstract][Full Text] [Related]
15. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer. Ahn JY; Lee JS; Min HY; Lee HY Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450 [TBL] [Abstract][Full Text] [Related]
16. Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer. Ishibiki Y; Kitajima M; Sakamoto K; Tomiki Y; Sakamoto S; Kamano T J Int Med Res; 2003; 31(3):181-7. PubMed ID: 12870370 [TBL] [Abstract][Full Text] [Related]
17. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Fujii R; Seshimo A; Kameoka S Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524 [TBL] [Abstract][Full Text] [Related]
19. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells. Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks. Wang W; McLeod HL; Cassidy J; Collie-Duguid ES Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]